Michele Simbolo
Overview
Explore the profile of Michele Simbolo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
82
Citations
2277
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sabella G, Centonze G, Maisonneuve P, Grillo F, Lagano V, Garzone G, et al.
J Pathol Clin Res
. 2025 Mar;
11(2):e70020.
PMID: 40047117
Pulmonary typical carcinoids (TCs) are uncommon, well-differentiated neuroendocrine tumors of the lung that do not exhibit necrosis and have fewer than two mitoses per 2 mm, as defined by the...
2.
Mattiolo P, Bevere M, Mafficini A, Verschuur A, Calicchia M, Hackeng W, et al.
Endocr Pathol
. 2024 Sep;
35(4):354-361.
PMID: 39331358
Glucagonomas are functioning pancreatic neuroendocrine tumors (PanNETs) responsible for glucagonoma syndrome. This study aims to shed light on the clinicopathological and molecular features of these neoplasms. Six patients with glucagonomas...
3.
Sposito M, Belluomini L, Nocini R, Insolda J, Scaglione I, Menis J, et al.
Front Oncol
. 2024 Jul;
14:1436588.
PMID: 39045557
Introduction: To date, for all non-small cell lung cancer (NSCLC) cases, it is recommended to test for driver alterations to identify actionable therapeutic targets. In this light, comprehensive genomic profiling...
4.
Masetto F, Mafficini A, Saka B, Armutlu A, Chatterjee D, Jang K, et al.
Am J Surg Pathol
. 2024 Jul;
48(9):1082-1092.
PMID: 38946053
A type of cholangiocarcinoma (CCA) characterized by peculiar histologic patterns and underlying adenofibromatous lesions has been reported in the literature mostly as individual case reports. This study aims to further...
5.
Angerilli V, Sabella G, Simbolo M, Lagano V, Centonze G, Gentili M, et al.
Br J Cancer
. 2024 May;
131(1):159-170.
PMID: 38729995
Background: High-grade gastro-entero-pancreatic neoplasms (HG GEP-NENs) can be stratified according to their morphology and Ki-67 values into three prognostic classes: neuroendocrine tumors grade 3 (NETs G3), neuroendocrine carcinomas with Ki-67 ...
6.
Simbolo M, Centonze G, Gkountakos A, Monti V, Maisonneuve P, Golovco S, et al.
Virchows Arch
. 2024 Jan;
484(5):777-788.
PMID: 38168015
Pulmonary large cell carcinoma (LCC) is an undifferentiated neoplasm lacking morphological, histochemical, and immunohistochemical features of small cell lung cancer, adenocarcinoma (ADC), or squamous cell carcinoma (SCC). The available molecular...
7.
Sposito M, Scaglione I, Eccher S, Pasqualin L, Avancini A, Colato C, et al.
JTO Clin Res Rep
. 2023 Dec;
4(12):100597.
PMID: 38124787
Background: Enteric-type adenocarcinoma of the lung (lung-ETAC) is a rare form of lung cancer with histologic similarities to colorectal cancer, with aggressive behavior and unfavorable prognosis. Case Presentation: An 81-year-old...
8.
Bruno R, Simbolo M, Petrini I
Front Oncol
. 2023 Nov;
13:1310331.
PMID: 38023142
No abstract available.
9.
Bevere M, Masetto F, Carazzolo M, Bettega A, Gkountakos A, Scarpa A, et al.
Diagnostics (Basel)
. 2023 Sep;
13(17).
PMID: 37685358
Neuroendocrine neoplasms (NENs) are a heterogeneous group of diseases that are characterized by different behavior and clinical manifestations. The diagnosis and management of this group of tumors are challenging due...
10.
Mattiolo P, Gkountakos A, Centonze G, Bevere M, Piccoli P, Ammendola S, et al.
Pathol Res Pract
. 2023 Jul;
248:154674.
PMID: 37454491
Background: Intestinal neuroendocrine tumours (I-NETs) represent a non-negligible entity among intestinal neoplasms, with metastatic spreading usually present at the time of diagnosis. In this context, effective molecular actionable targets are...